{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:25:47Z","timestamp":1777461947090,"version":"3.51.4"},"reference-count":255,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jconrel.2020.08.060","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T15:17:35Z","timestamp":1598887055000},"page":"112-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Nanotheranostics against COVID-19: From multivalent to immune-targeted materials"],"prefix":"10.1016","volume":"328","author":[{"given":"Parichehr","family":"Hassanzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5168","key":"10.1016\/j.jconrel.2020.08.060_bb0005","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/220650b0","article-title":"Virology: Coronaviruses","volume":"220","author":"Almeida","year":"1968","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.060_bb0010","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3390\/v2081803","article-title":"Coronavirus genomics and bioinformatics analysis","volume":"2","author":"Woo","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0015","article-title":"Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China","author":"Lam","year":"2020","journal-title":"bioRxiv."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0020","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.celrep.2019.08.052","article-title":"Structural definition of a neutralization-sensitive epitope on the MERS-CoV S1-NTD","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.celrep.2018.06.041","article-title":"Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV spike glycoprotein","volume":"24","author":"Zhang","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0030","article-title":"SARS-CoV-2 and SARS-CoV spike-RBD structure and receptor binding comparison and potential implications on neutralizing antibody and vaccine development","author":"Sun","year":"2020","journal-title":"bioRxiv."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0035","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.060_bb0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.antiviral.2013.09.028","article-title":"Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research","volume":"100","author":"Simmons","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117836","article-title":"Coronaviruses pandemics: Can neutralizing antibodies help?","volume":"255","author":"Tong","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0050","series-title":"Hagan and Bruner\u2019s Microbiology and Infectious Diseases of Domestic Animals: With Reference to Etiology, Epizootiology, Pathogenesis, Immunity, Diagnosis, and Antimicrobial Susceptibility","first-page":"440","author":"Hagan","year":"1988"},{"issue":"11 Suppl","key":"10.1016\/j.jconrel.2020.08.060_bb0055","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1097\/01.inf.0000188166.17324.60","article-title":"History and recent advances in coronavirus discovery","volume":"24","author":"Kahn","year":"2005","journal-title":"The Pediatric Infectious Disease Journal."},{"issue":"5297","key":"10.1016\/j.jconrel.2020.08.060_bb0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.2.5297.82","article-title":"Virus isolations from common colds occurring in a residential school","volume":"2","author":"Kendall","year":"1962","journal-title":"Br Med J"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0065","series-title":"Ninth Report of the International Committee on Taxonomy of Viruses","article-title":"Family Coronaviridae","volume":"806\u2013828","author":"de Groot","year":"2011"},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.060_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trend Microbiol"},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.060_bb0075","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"New Eng J Med"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0080","series-title":"The Springer Index of Viruses","first-page":"371","author":"Decaro","year":"2011"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and Sources of Endemic Human Coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0090","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health\u2014The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int J Infectious Dis"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0095","doi-asserted-by":"crossref","unstructured":"Neher RA, Dyrdak R, Druelle V, Hodcroft EB, Albert J. Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. MedRxiv 2020.","DOI":"10.1101\/2020.02.13.20022806"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0105","series-title":"Coronavirus (COVID-19) update: Serological tests","author":"Hahn","year":"2020"},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.060_bb0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1021\/acscentsci.0c00501","article-title":"Assay Techniques and Test Development for COVID-19 Diagnosis","volume":"6","author":"Carter","year":"2020","journal-title":"ACS Cent Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.19.1.165-256.2006","article-title":"Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing","volume":"19","author":"Espy","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.060_bb0120","first-page":"155","article-title":"Pitfalls of Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction","volume":"15","author":"Bustin","year":"2004","journal-title":"J Biomol Tech."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0125","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/14737159.2020.1757437","article-title":"Real-time RT-PCR in COVID-19 detection: issues affecting the results","volume":"20","author":"Tahamtan","year":"2020","journal-title":"Expert Rev Mol Diagn."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0130","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CJI.0b013e31816dad10","article-title":"A Multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer","volume":"31","author":"Chianese-Bullock","year":"2008","journal-title":"J Immunother"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.febslet.2013.10.014","article-title":"Protein Engineering Strategies for the Development of Viral Vaccines and Immunotherapeutics","volume":"588","author":"Koellhoffer","year":"2014","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.060_bb0140","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.060_bb0145","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2147\/DDDT.S67861","article-title":"Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach","author":"Oany","year":"2014","journal-title":"Drug Design Dev Ther"},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.060_bb0150","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: Current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0155","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/521231","article-title":"Peptide-Based Vaccinology: Experimental and Computational Approaches to Target Hypervariable Viruses through the Fine Characterization of Protective Epitopes Recognized by Monoclonal Antibodies and the Identification of T-Cell-Activating Peptides","volume":"2013","author":"Castelli","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0160","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1586\/14760584.6.6.939","article-title":"Epitope-based vaccine against influenza","volume":"6","author":"Ben-Yedidia","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1099\/vir.0.036640-0","article-title":"A cross-protective mAb recognizes a novel epitope within the flavivirus NS1 protein","volume":"93","author":"Lee","year":"2012","journal-title":"J General Virol"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.antiviral.2011.07.013","article-title":"A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza","volume":"92","author":"Mancini","year":"2011","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.060_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00063030-200721030-00002","article-title":"Epitope mapping: the first step in developing epitope-based vaccines","volume":"21","author":"Gershoni","year":"2007","journal-title":"BioDrugs"},{"issue":"9","key":"10.1016\/j.jconrel.2020.08.060_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001295","article-title":"In silico analysis of six known leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response","volume":"5","author":"Seyed","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.060_bb0185","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1586\/erv.09.26","article-title":"How to design effective vaccines: lessons from an old success story","volume":"8","author":"Ahmed","year":"2009","journal-title":"Expert Rev Vaccines."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/bmb\/62.1.201","article-title":"Vaccine programmes and policies","volume":"62","author":"Miller","year":"2002","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/21645515.2015.1093263","article-title":"Primary vaccine failure to routine vaccines: Why and what to do?","volume":"12","author":"Wiedermann","year":"2016","journal-title":"Hum. Vaccines Immunotherapeutics."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0200","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01023-18","article-title":"Engineered Dengue Virus Domain III Proteins Elicit Cross- Neutralizing Antibody Responses in Mice","volume":"92","author":"Frei","year":"2018","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.060_bb0205","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/nsr\/nwaa036","article-title":"On the origin and continuing evolution of SARS-CoV-2","volume":"7","author":"Tang","year":"2020","journal-title":"Natl Sci Rev"},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.060_bb0210","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3390\/v12050526","article-title":"SARS-CoV-2\/COVID-19: Viral genomics, epidemiology, vaccines, and therapeutic interventions","volume":"12","author":"Uddin","year":"2020","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.060_bb0215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/vaccines8020153","article-title":"Progress and prospects on vaccine development against SARS-CoV-2","volume":"8","author":"Zhang","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0220","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3389\/fimmu.2019.00594","article-title":"Advances in mRNA Vaccines for Infectious Diseases","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0225","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1007\/s00253-014-5639-1","article-title":"Virus-like particles in picornavirus vaccine development","volume":"98","author":"Dong","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0230","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3201\/eid1103.040906","article-title":"Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes","volume":"11","author":"Temperton","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0235","first-page":"406","article-title":"Mechanism of immunopotentiation and safety of aluminum adjuvants","volume":"3","author":"Hogenesch","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: Helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0245","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-015-0350-4","article-title":"Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs","volume":"38","author":"Petrovsky","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0250","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/d41586-020-00751-9","article-title":"Don\u2019t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees","volume":"579","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0255","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0260","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.060_bb0265","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dsx.2020.03.011","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0270","series-title":"Hydroxychloroquine and Chloroquine Retinopathy","first-page":"35","article-title":"Pharmacology of Chloroquine and Hydroxychloroquine","volume":"4","author":"Browning","year":"2014"},{"issue":"10236","key":"10.1016\/j.jconrel.2020.08.060_bb0275","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0280","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe COVID-19","volume":"382","author":"Grein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0285","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0290","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe COVID-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study","author":"Cai","year":"2020","journal-title":"Engineering"},{"issue":"9","key":"10.1016\/j.jconrel.2020.08.060_bb0300","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.3390\/v10090453","article-title":"Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus","volume":"10","author":"Saiz","year":"2018","journal-title":"Viruses"},{"issue":"19","key":"10.1016\/j.jconrel.2020.08.060_bb0305","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0310","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circulation Res."},{"issue":"18","key":"10.1016\/j.jconrel.2020.08.060_bb0315","first-page":"1769","article-title":"COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?","volume":"323","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0320","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0325","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41422-020-0290-0","article-title":"Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses","volume":"30","author":"Nguyen","year":"2020","journal-title":"Cell Res"},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.060_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007756","article-title":"The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression","volume":"15","author":"Grunewald","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0335","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cr.2008.15","article-title":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0340","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0345","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tcb.2009.12.005","article-title":"An emerging role for p21-activated kinases (Paks) in viral infections","volume":"20","author":"Van den Broeke","year":"2010","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0350","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2016.11.038","article-title":"1,2,3-Triazolyl ester of Ketorolac: A \u201cClick Chemistry\u201d-based highly potent PAK1-blocking cancer-killer","volume":"126","author":"Nguyen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0355","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5582\/ddt.2017.01011","article-title":"Frondoside A from sea cucumber and nymphaeols from Okinawa propolis: Natural anti-cancer agents that selectively inhibit PAK1 in vitro","volume":"11","author":"Nguyen","year":"2017","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0360","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12250-020-00207-4","article-title":"Understanding SARS-CoV-2-mediated inflammatory responses: From mechanisms to potential therapeutic tools","volume":"35","author":"Fu","year":"2020","journal-title":"Virol Sin"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0365","article-title":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus","author":"Zhou","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0370","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1473-3099(20)30141-9","article-title":"Convalescent plasma as a potential therapy for COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0375","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tracli.2015.12.003","article-title":"Plasma therapy against infectious pathogens, as of yesterday, today andtomorrow","volume":"23","author":"Garraud","year":"2016","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0380","author":"National Health Commission of the People's Republic of China"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0385","first-page":"1","article-title":"Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein","volume":"278","author":"Gooa","year":"2020","journal-title":"Virus Research"},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.060_bb0390","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/14712598.2020.1770222","article-title":"Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces","volume":"20","author":"Gonz\u00e1lez-Gay","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0395","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0400","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0405","article-title":"Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0410","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cmdc.201300555","article-title":"Toward drug repurposing in epigenetics: olsalazine as a hypomethylating compound active in a cellular context","volume":"9","author":"M\u00e9ndez-Lucio","year":"2014","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0415","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/nprot.2016.123","article-title":"A decade of progress in tissue engineering","volume":"11","author":"Khademhosseini","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.14748\/bmr.v23.26","article-title":"Tissue engineering and growth factors: updated evidence","volume":"23","author":"Hassanzadeh","year":"2012","journal-title":"Biomed Rev"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0425","series-title":"Role of tissue engineering in COVID-19 and future viral outbreaks","first-page":"468","volume":"26","author":"Tatara","year":"2020"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0430","first-page":"246","article-title":"In vitro models to study human lung development, disease and homeostasis","volume":"32","author":"Miller","year":"2017","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0435","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2018.04.024","article-title":"Tissue engineering: Still facing a long way ahead","volume":"279","author":"Hassanzadeh","year":"2018","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0440","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.addr.2019.05.001","article-title":"The significance of artificial intelligence in drug delivery system design","volume":"151\u2013152","author":"Hassanzadeh","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0445","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1389201053167248","article-title":"Nanotechnology on duty in medical applications","volume":"6","author":"Kubik","year":"2005","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0450","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14748\/bmr.v25.1043","article-title":"Nanopharmaceuticals: Innovative theranostics for the neurological disorders","volume":"25","author":"Hassanzadeh","year":"2014","journal-title":"Biomed Rev"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.060_bb0455","first-page":"105","article-title":"New perspectives in biosensor technology","volume":"3","author":"Hassanzadeh","year":"2010","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0460","first-page":"1","article-title":"Can nanotechnology help in the fight against COVID-19?","volume":"1","author":"Palestino","year":"2020","journal-title":"Expert Rev Anti-infective Therapy"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0465","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3181\/0904-MR-134","article-title":"Engineering Nanomaterial Surfaces for Biomedical Applications","volume":"234","author":"Wang","year":"2009","journal-title":"Exp Biol Med."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0470","first-page":"S2207","article-title":"Development of SPR biosensor for simultaneous detection of multiplex respiratory viruses","volume":"26","author":"Shi","year":"2015","journal-title":"Biomed Mater Eng."},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.060_bb0475","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jbiosc.2011.08.014","article-title":"Novel system for detecting SARS coronavirus nucleocapsid protein using an ssDNA aptamer","volume":"112","author":"Cho","year":"2011","journal-title":"J Biosci Bioeng."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0480","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1166\/jnn.2011.3269","article-title":"Development of reflective biosensor using fabrication of functionalized photonic nanocrystals","volume":"11","author":"Park","year":"2011","journal-title":"J Nanosci Nanotechnol."},{"issue":"11","key":"10.1016\/j.jconrel.2020.08.060_bb0485","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1021\/nn101198u","article-title":"Importance of controlling nanotube density for highly sensitive and reliable biosensors functional in physiological conditions","volume":"4","author":"Ishikawa","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0490","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bios.2012.02.001","article-title":"A highly selective and colorimetric assay of lysine by molecular-driven gold nanorods assembly","volume":"34","author":"Wang","year":"2012","journal-title":"Biosensors Bioelectronics"},{"issue":"17","key":"10.1016\/j.jconrel.2020.08.060_bb0495","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/adhm.201600334","article-title":"Highly sensitive molecular detection platform for robust and facile diagnosis of middle east respiratory Syndrome (MERS) corona virus","volume":"5","author":"Jung","year":"2016","journal-title":"Adv Healthc Mater."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0500","first-page":"237","article-title":"Colorimetric biosensors for point-of-care virus detections","volume":"3","author":"Ting Zhao","year":"2020","journal-title":"Mater Sci Energy Technol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0505","article-title":"Rapid multiplex microfiber-based immunoassay for anti-MERS-CoV antibody detection","volume":"26","author":"Hoy","year":"2019","journal-title":"Sens Biosensing Res."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.060_bb0510","doi-asserted-by":"crossref","DOI":"10.1007\/s00604-019-3345-5","article-title":"An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes","volume":"186","author":"Layqah","year":"2019","journal-title":"Mikrochim Acta."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0515","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.enzmictec.2016.09.006","article-title":"Rapid detection of viral antibodies based on multifunctional Staphylococcus aureus nanobioprobes","volume":"95","author":"Qiao","year":"2016","journal-title":"Enzyme Microb Technol."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.060_bb0520","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1021\/acsnano.0c02439","article-title":"Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection","volume":"14","author":"Qiu","year":"2020","journal-title":"ACS Nano."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.060_bb0525","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1021\/acsnano.0c02823","article-title":"Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor","volume":"14","author":"Seo","year":"2020","journal-title":"ACS Nano."},{"issue":"38","key":"10.1016\/j.jconrel.2020.08.060_bb0530","doi-asserted-by":"crossref","first-page":"21571","DOI":"10.1021\/acsami.5b06876","article-title":"Antiviral activity of graphene oxide: how sharp edged structure and charge matter","volume":"7","author":"Ye","year":"2015","journal-title":"ACS App Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.060_bb0535","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/ijerph13040430","article-title":"Antiviral activity of graphene\u2013 silver nanocomposites against non-enveloped and enveloped viruses","volume":"13","author":"Chen","year":"2016","journal-title":"Int J Environ Res Public Health."},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.060_bb0540","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/AEM.03427-13","article-title":"Antiviral properties of silver nanoparticles on a magnetic hybrid colloid","volume":"80","author":"Park","year":"2014","journal-title":"Appl Environ Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0545","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-3155-3-6","article-title":"Interaction of silver nanoparticles with HIV-1","volume":"3","author":"Elechiguerra","year":"2005","journal-title":"J Nanobiotechnology."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.060_bb0550","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1021\/acsami.7b13811","article-title":"Glutathione-capped Ag2S nanoclusters inhibit coronavirus proliferation through blockage of viral RNA synthesis and budding","volume":"10","author":"Du","year":"2018","journal-title":"ACS Appl Mater."},{"issue":"46","key":"10.1016\/j.jconrel.2020.08.060_bb0555","doi-asserted-by":"crossref","first-page":"42964","DOI":"10.1021\/acsami.9b15032","article-title":"Functional carbon quantum dots as medical countermeasures to human coronavirus","volume":"11","author":"Loczechin","year":"2019","journal-title":"ACS Appl Mater."},{"issue":"10","key":"10.1016\/j.jconrel.2020.08.060_bb0560","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1021\/acsanm.8b00779","article-title":"Multisite inhibitors for enteric coronavirus: antiviral cationic carbon dots based on curcumin","volume":"1","author":"Ting","year":"2018","journal-title":"ACS Appl Nano Mater."},{"issue":"20","key":"10.1016\/j.jconrel.2020.08.060_bb0565","doi-asserted-by":"crossref","first-page":"7646","DOI":"10.1021\/la300948n","article-title":"Nanoparticles and surfaces presenting antifungal, antibacterial and antiviral properties","volume":"28","author":"Botequim","year":"2012","journal-title":"Langmuir."},{"issue":"6277","key":"10.1016\/j.jconrel.2020.08.060_bb0570","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.aad2450","article-title":"Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer","volume":"351","author":"Lee","year":"2016","journal-title":"Science."},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.060_bb0575","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1128\/JVI.03256-13","article-title":"Surfactant-modified nanoclay exhibits an antiviral activity with high potency and broad spectrum","volume":"88","author":"Liang","year":"2014","journal-title":"J Virol."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0580","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/am2014103","article-title":"Characterization, antimicrobial activities, and biocompatibility of organically modified clays and their nanocomposites with polyurethane","volume":"4","author":"Wang","year":"2012","journal-title":"ACS Appl Mater."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.060_bb0585","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/19\/7\/075106","article-title":"Photoinduced antiviral carbon nanohorns","volume":"19","author":"Miyako","year":"2008","journal-title":"Nanotechnology."},{"issue":"10","key":"10.1016\/j.jconrel.2020.08.060_bb0590","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/23\/10\/105101","article-title":"Light-activated nanotube\u2013porphyrin conjugates as effective antiviral agents","volume":"23","author":"Banerjee","year":"2012","journal-title":"Nanotechnology."},{"issue":"25","key":"10.1016\/j.jconrel.2020.08.060_bb0595","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5813","article-title":"Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2","volume":"6","author":"Di Giorgio","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0600","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5813","article-title":"Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2","author":"Di Giorgio","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0605","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/msb.2012.66","article-title":"Genome-scale engineering for systems and synthetic biology","volume":"9","author":"Esvelt","year":"2013","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0610","first-page":"167","article-title":"Carbon nanotubes prolong the regulatory action of nerve growth factor on the endocannabinoid signaling","volume":"19","author":"Hassanzadeh","year":"2015","journal-title":"Physiol Pharmacol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0615","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.lfs.2016.11.015","article-title":"Application of carbon nanotubes as the carriers of the cannabinoid, 2-arachidonoylglycerol: Towards a novel treatment strategy in colitis","volume":"179","author":"Hassanzadeh","year":"2017","journal-title":"Life Sciences"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0620","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lfs.2016.11.029","article-title":"Nerve growth factor-carbon nanotube complex exerts prolonged protective effects in an in vitro model of ischemic stroke","volume":"179","author":"Hassanzadeh","year":"2017","journal-title":"Life Sciences"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0625","doi-asserted-by":"crossref","first-page":"41","DOI":"10.14748\/bmr.v27.2105","article-title":"Application of Carbon Nanotubes for Controlled Release of Growth Factors or Endocannabinoids: A Breakthrough in Biomedicine","volume":"27","author":"Hassanzadeh","year":"2017","journal-title":"Biomed. Rev."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0630","first-page":"38","article-title":"Carbon nanotubes provide longer lasting gastroprotective effects for anandamide in stressinduced gastric ulcer in rat","volume":"22","author":"Hassanzadeh","year":"2018","journal-title":"Physiol Pharmacol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquaculture.2019.734377","article-title":"Anti-betanodavirus activity of isoprinosine and improved efficacy using carbon nanotubes based drug delivery system","volume":"512","author":"Zhu","year":"2019","journal-title":"Aquaculture"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0640","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.antiviral.2015.03.006","article-title":"Carbon nanotube-based nanocarrier loaded with ribavirin against grass carp reovirus","volume":"118","author":"Zhu","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0645","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41565-019-0382-5","article-title":"High aspect ratio nanomaterials enable delivery of functional genetic material without DNA integration in mature plants","volume":"14","author":"Demirer","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0650","doi-asserted-by":"crossref","DOI":"10.1186\/s40199-017-0191-z","article-title":"Application of nanostructured lipid carriers: the prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway","volume":"25","author":"Hassanzadeh","year":"2017","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0655","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.lfs.2017.11.046","article-title":"Ferulic acid-loaded nanostructured lipid carriers: A promising nanoformulation against the ischemic neural injuries","volume":"193","author":"Hassanzadeh","year":"2018","journal-title":"Life Sciences"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0660","first-page":"331","article-title":"Aerosol delivery of ferulic acid-loaded nanostructured lipid carriers: A promising treatment approach against the respiratory disorders","volume":"21","author":"Hassanzadeh","year":"2017","journal-title":"Physiol Pharmacol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0665","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14748\/bmr.v28.4449","article-title":"Nanoencapsulation: A promising strategy for biomedical applications of ferulic acid","volume":"28","author":"Hassanzadeh","year":"2017","journal-title":"Biomed. Rev."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0670","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14748\/bmr.v25.1043","article-title":"Nanopharmaceuticals: Innovative theranostics for the neurological disorders","volume":"25","author":"Hassanzadeh","year":"2014","journal-title":"Biomed. Rev."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0675","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14630","article-title":"Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge","volume":"8","author":"Pardi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0680","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ymthe.2019.03.003","article-title":"Non-viral delivery of zinc finger nuclease mRNA enables highly efficient in vivo genome editing of multiple therapeutic gene targets","volume":"27","author":"Conway","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0685","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0690","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/13543784.15.2.89","article-title":"Antiviral applications of RNAi for Coronavirus","volume":"15","author":"Wu","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0695","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/135965350400900310","article-title":"Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus","volume":"9","author":"Zheng","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0700","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/sj.gt.3302645","article-title":"Antiviral RNAi therapy: emerging approaches for hitting a moving target","volume":"13","author":"Leonard","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0705","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1280","article-title":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque","volume":"11","author":"Li","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0710","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/MMBR.00015-08","article-title":"Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation","volume":"72","author":"Frieman","year":"2008","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0715","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.3390\/molecules15107197","article-title":"Small Interfering RNA Effectively Inhibits the Expression of SARS Coronavirus Membrane Gene at Two Novel Targeting Sites","volume":"15","author":"Wang","year":"2010","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.060_bb0720","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2007.06.015","article-title":"Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome","volume":"47","author":"Watanabe","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/161794","article-title":"Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives","volume":"2014","author":"Torrecilla","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0730","series-title":"Liver Disease Associated with Non-Hepatitis Viruses. Encyclopedia of Gastroenterology","first-page":"363","author":"Spengler","year":"2020"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0735","first-page":"1","article-title":"Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I","volume":"1805308","author":"Cheng","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0740","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41565-020-0666-9","article-title":"Nanotechnology for organ-tunable gene editing","volume":"15","author":"van der Meel","year":"2020","journal-title":"Nat Nanotechnol"},{"issue":"11","key":"10.1016\/j.jconrel.2020.08.060_bb0745","first-page":"1007","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Strategic directions to improve translation and exploitation. Nat Nanotechnol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ange.201608450","article-title":"Polymer\u2013Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs","volume":"128","author":"Kaczmarek","year":"2016","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0755","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0760","series-title":"Acc. Chem. Res","first-page":"2435","volume":"52","author":"Kulkarni","year":"2019"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0765","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0770","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","article-title":"Nanoparticles: Properties, applications and toxicities","volume":"12","author":"Khan","year":"2019","journal-title":"Arab J Chem"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0775","doi-asserted-by":"crossref","unstructured":"Andreas Reichmuth, Matthias Oberli, Ana Jeklenec, Robert S Langer. mRNA vaccine delivery using lipid nanoparticles. Therapeutic Delivery 7(5):319-334.","DOI":"10.4155\/tde-2016-0006"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0780","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/17425247.2014.901308","article-title":"Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines","volume":"11","author":"Deering","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0785","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.vaccine.2018.01.029","article-title":"Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity","volume":"36","author":"John","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0790","first-page":"1","article-title":"Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther."},{"issue":"29","key":"10.1016\/j.jconrel.2020.08.060_bb0795","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/j.vaccine.2009.04.001","article-title":"Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirusspecific cytotoxic T lymphocytes and viral clearance in HLA-A* 0201 transgenic mice","volume":"27","author":"Ohno","year":"2009","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0800","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1348-0421.12754","article-title":"Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs","volume":"64","author":"Sekimukai","year":"2020","journal-title":"Microbiol Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.060_bb0805","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2567.2007.02676.x","article-title":"Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice","volume":"122","author":"Lu","year":"2007","journal-title":"Immunology."},{"issue":"38","key":"10.1016\/j.jconrel.2020.08.060_bb0810","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2011.06.111","article-title":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0815","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/wnan.119","article-title":"Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design","volume":"3","author":"Plummer","year":"2011","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0820","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","article-title":"COVID-19 vaccine development and a potential nanomaterial path forward","volume":"15","author":"Shin","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0825","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/advances\/nmz013","article-title":"The role of zinc in antiviral immunity","volume":"10","author":"Read","year":"2019","journal-title":"Adv Nutr."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0830","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discoveries Ther."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0835","first-page":"432","article-title":"Global epidemic of coronavirus\u2014covid-19: what can we do to minimize risks","volume":"7","author":"Wimalawansa","year":"2020","journal-title":"Eur. J Biomed."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0840","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0845","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2015.10.012","article-title":"Nanotechnology for Protein Delivery: Overview and Perspectives","volume":"240","author":"Yu","year":"2016","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0850","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1530","article-title":"Nanoscale Platforms for Messenger RNA Delivery","volume":"11","author":"Li","year":"2019","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0855","article-title":"PLGA, PLGA-TMC and TMC-TPP Nanoparticles Differentially Modulate the Outcome of Nasal Vaccination by Inducing Tolerance or Enhancing Humoral Immunity","volume":"6","author":"van der Zee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0860","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2020.03.007","article-title":"SARS-CoV-2 Vaccines: Status Report","volume":"52","author":"Amanat","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0865","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an Inactivated Vaccine Candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0870","doi-asserted-by":"crossref","DOI":"10.1038\/srep19570","article-title":"Different Human Vaccine Adjuvants Promote Distinct Antigen-Independent Immunological Signatures Tailored to Different Pathogens","volume":"6","author":"Knudsen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0875","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1039\/C6TB01131D","article-title":"Nanomaterial-Based Vaccine Adjuvants","volume":"4","author":"Sun","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0880","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1021\/acsnano.5b04751","article-title":"Crucial Role of Lateral Size for Graphene Oxide in Activating Macrophages and Stimulating Pro-Inflammatory Responses in Cells and Animals","volume":"9","author":"Ma","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0885","doi-asserted-by":"crossref","DOI":"10.1088\/2515-7639\/ab9317","article-title":"Graphene, Other Carbon Nanomaterials and the Immune System: Toward Nanoimmunity-by-Design","volume":"3","author":"Gazzi","year":"2020","journal-title":"J Phys Mater"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0890","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1479-5876-12-138","article-title":"Impact of Carbon Nanotubes and Graphene on Immune Cells","volume":"12","author":"Orecchioni","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0895","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.01.064","article-title":"Carboxyl- and Amino-Functionalized Polystyrene Nanoparticles Differentially Affect the Polarization Profile of M1 and M2 Macrophage Subsets","volume":"85","author":"Fuchs","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0900","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.carbon.2020.01.003","article-title":"Impact of the Surface Functionalization on Nanodiamond Biocompatibility: A Comprehensive View on Human Blood Immune Cells","volume":"160","author":"Fusco","year":"2020","journal-title":"Carbon"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0905","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01015-3","article-title":"Single-Cell Mass Cytometry and Transcriptome Profiling Reveal the Impact of Graphene on Human Immune Cells","volume":"8","author":"Orecchioni","year":"2017","journal-title":"Nat. Commun."},{"issue":"38","key":"10.1016\/j.jconrel.2020.08.060_bb0910","first-page":"1","article-title":"Immune Responses in COVID-19 and Potential Vaccines: Lessons Learned from SARS and MERS Epidemic","author":"Prompetchara","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0915","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0920","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17425247.2018.1420053","article-title":"Nanomedicine for Immunosuppressive Therapy: Achievements in Pre-Clinical and Clinical Research","volume":"15","author":"Al-Lawati","year":"2018","journal-title":"Expert Opin. Drug Delivery"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0925","doi-asserted-by":"crossref","unstructured":"Chen, Y.; Feng, Z.; Diao, B.; Wang, R.; Wang, G.; Wang, C.; et al. The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV- 2) Directly Decimates Human Spleens and Lymph Nodes. medRxiv 2020, DOI: https:\/\/doi.org\/10.1101\/2020.03.27.20045427.","DOI":"10.1101\/2020.03.27.20045427"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0930","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/rb\/rbz012","article-title":"Immunomodulatory Nanodiamond Aggregate-Based Platform for the Treatment of Rheumatoid Arthritis","volume":"6","author":"Pentecost","year":"2019","journal-title":"Regen. Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb0935","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/adhm.201200044","article-title":"Hierarchical Porous Carbide-Derived Carbons for the Removal of Cytokines from Blood Plasma","author":"Presser","year":"2012","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0940","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/acsabm.8b00151","article-title":"Graphene-Based Materials for the Fast Removal of Cytokines from Blood Plasma","volume":"1","author":"Seredych","year":"2018","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0945","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0924-8579(03)00035-9","article-title":"Local Treatment of Viral Disease Using Photodynamic Therapy","volume":"21","author":"Wainwright","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0950","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1039\/c9pp00211a","article-title":"Trends and Targets in Antiviral Phototherapy","volume":"18","author":"Wiehe","year":"2019","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0955","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1021\/jacs.5b12950","article-title":"Pathogen Inhibition by Multivalent Ligand Architectures","volume":"138","author":"Bhatia","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0960","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral Drugs in Current Clinical Use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J. Clin. Virol."},{"issue":"42","key":"10.1016\/j.jconrel.2020.08.060_bb0965","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1002\/anie.201201114","article-title":"Multivalency as a chemical organization and action principle","volume":"51","author":"Fasting","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0970","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1039\/C4MD00143E","article-title":"Multivalent glycoconjugates as vaccines and potential drug candidates","volume":"5","author":"Bhatia","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0975","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0035","article-title":"The role of cellular adhesion molecules in virus attachment and entry","volume":"370","author":"Bhella","year":"2015","journal-title":"Philos. Trans. R. Soc., B"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0980","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.med.59.061506.213121","article-title":"Medical Management of Influenza Infectio","volume":"59","author":"Moscona","year":"2008","journal-title":"Rev. Med."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0985","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/14740330902840519","article-title":"Oseltamivir for treatment and prophylaxis of influenza infection","volume":"8","author":"Schirmer","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jconrel.2020.08.060_bb0990","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cbic.201000776","article-title":"Inhibition of influenza virus activity by multivalent glycoarchitectures with matched sizes","volume":"12","author":"Papp","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jconrel.2020.08.060_bb0995","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1021\/acs.nanolett.5b02256","article-title":"Multivalency at Interfaces: Supramolecular Carbohydrate-Functionalized Graphene Derivatives for Bacterial Capture, Release, and Disinfection","volume":"15","author":"Qi","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1000","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/smll.200902384","article-title":"Inhibition of HSV-1 Attachment, Entry, and Cell-to-Cell Spread by Functionalized Multivalent Gold Nanoparticles","volume":"6","author":"Baram-Pinto","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1005","doi-asserted-by":"crossref","DOI":"10.4238\/2014.March.19.2","article-title":"Inhibition Effect of Silver Nanoparticles on Herpes Simplex Virus 2. GMR","volume":"13","author":"Hu","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1010","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1039\/C7NR00611J","article-title":"Size-Dependent Inhibition of Herpesvirus Cellular Entry by Polyvalent Nanoarchitectures","volume":"9","author":"Ziem","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1015","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1039\/c3nr04449a","article-title":"Virus Inhibition Induced by Polyvalent Nanoparticles of Different Sizes","volume":"6","author":"Vonnemann","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1020","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1002\/smll.201001349","article-title":"Inhibition of Influenza Virus Infection by Multivalent Sialic-Acid-Functionalized Gold Nanoparticles","volume":"6","author":"Papp","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nmat5053","article-title":"Broad-Spectrum Non-Toxic Antiviral Nanoparticles with a Virucidal Inhibition Mechanism","volume":"17","author":"Cagno","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1030","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1021\/acsnano.0c02857","article-title":"Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2","volume":"14","author":"Han","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1035","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cbic.201000776","article-title":"Inhibition of Influenza Virus Activity by Multivalent Glycoarchitectures with Matched Sizes","volume":"12","author":"Papp","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1040","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1021\/acsnano.8b01616","article-title":"Multivalent Flexible Nanogels Exhibit Broad-Spectrum Antiviral Activity by Blocking Virus Entry","volume":"12","author":"Dey","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1045","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/adhm.201600812","article-title":"Highly Efficient Multivalent 2D Nanosystems for Inhibition of Orthopoxvirus Particles","volume":"5","author":"Ziem","year":"2016","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1050","first-page":"1","article-title":"Functionalized Graphene as Extracellular Matrix Mimics: Toward Well-Defined 2D Nanomaterials for Multivalent Virus Interactions","volume":"1606477","author":"Mohammad Fardin Gholami","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1055","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s11051-012-1320-8","article-title":"Recent Advances in Graphene Family Materials Toxicity Investigations","volume":"14","author":"Jastrz\u0119bska","year":"2012","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1060","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1002\/adfm.201000410","article-title":"Synthesis, Reductive Cleavage, and Cellular Interaction Studies of Biodegradable, Polyglycerol Nanogels","volume":"20","author":"Steinhilber","year":"2010","journal-title":"Adv. Funct. Mater."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.060_bb1065","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1021\/acs.nanolett.0c02278","article-title":"Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity","volume":"20","author":"Zhang","year":"2020","journal-title":"Nanoletters"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biomaterials.2017.09.020","article-title":"Bio-Inspired Engineering of Cell- and Virus-Like Nanoparticles for Drug Delivery","volume":"147","author":"Parodi","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.1190094","article-title":"Inorganic Nanoparticles as Protein Mimics","volume":"330","author":"Kotov","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1080","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1021\/acsnano.5b07360","article-title":"Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer Therapy","volume":"10","author":"Czapar","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1085","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(20)30894-1","article-title":"Flooded by the Torrent: The COVID-19 Drug Pipeline","volume":"395","author":"Mullard","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.060_bb1090","doi-asserted-by":"crossref","first-page":"FDD40","DOI":"10.4155\/fdd-2020-0010","article-title":"Drug Repurposing Strategies for COVID-19","volume":"2","author":"Senanayake","year":"2020","journal-title":"Future Drug Discovery"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jconrel.2018.04.042","article-title":"Ignoring the modeling approaches: Towards the shadowy paths in nanomedicine","volume":"280","author":"Hassanzadeh","year":"2018","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.lfs.2017.06.001","article-title":"Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders","volume":"182","author":"Hassanzadeh","year":"2017","journal-title":"Life Sciences"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14748\/bmr.v24.19","article-title":"Computational modelling: moonlighting on the neuroscience and medicine","volume":"24","author":"Hassanzadeh","year":"2013","journal-title":"Biomed Rev"},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.060_bb1110","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb1115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29459-7","article-title":"The structural model of Zika virus RNA-dependent RNA polymerase in complex with RNA for rational design of novel nucleotide inhibitors","volume":"8","author":"\u0160ebera","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1120","doi-asserted-by":"crossref","unstructured":"Shameer K, Johnson KW, Readhead B. Rapid Therapeutic Recommendations in the Context of a Global Public Health Crisis using Translational Bioinformatics Approaches: A proof-of-concept study using Nipah Virus Infection. bioRxiv; 333021 , https:\/\/doi.org\/10.1101\/333021.","DOI":"10.1101\/333021"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0668.2006.00452.x","article-title":"Identification of contaminant sources in enclosed environments by inverse CFD modeling","volume":"17","author":"Zhang","year":"2007","journal-title":"Indoor Air"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1130","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1016\/j.atmosenv.2011.07.049","article-title":"Impact of scaling and body movement on contaminant transport in airliner cabins","volume":"45","author":"Mazumdar","year":"2011","journal-title":"Atmos. Environ."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1135","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1021\/acs.jpcc.8b07616","article-title":"In Silico Study of Gold Nanoparticle Uptake into a Mammalian Cell: Interplay of Size, Shape, Surface Charge, and Aggregation","volume":"123","author":"Lunnoo","year":"2019","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41597-020-0477-8","article-title":"COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction Mechanisms","volume":"7","author":"Ostaszewski","year":"2020","journal-title":"Scientific Data"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1145","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/bib\/bby024","article-title":"Community-driven roadmap for integrated disease maps","volume":"20","author":"Ostaszewski","year":"2019","journal-title":"Brief. Bioinform"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1088\/0957-4484\/24\/45\/452002","article-title":"Artificial intelligence in nanotechnology","volume":"24","author":"Sacha","year":"2013","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187221007779814745","article-title":"Medical nanorobot architecture based on nano bioelectronics","volume":"1","author":"Cavalcanti","year":"2007","journal-title":"Recent Pat Nanotechnol"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb1160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1166\/ajrs.2014.1010","article-title":"Nanorobotic Applications in Medicine: Current Proposals and Designs","volume":"1","author":"Yamaan Saadeh","year":"2014","journal-title":"Am J Robot Surg."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1165","first-page":"349","article-title":"Equipment and technology in robotics","volume":"60","author":"Murphy","year":"2007","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1170","first-page":"37","article-title":"Creation of nanorobots: Both state-of-the science and state-of-the-art","volume":"27","author":"Hassanzadeh","year":"2016","journal-title":"Biomed. Rev."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/10611860600612862","article-title":"Nanorobot: A versatile tool in nanomedicine","volume":"14","author":"Patel","year":"2006","journal-title":"J Drug Target"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1180","article-title":"A remote-controlled generation of gold@polydopamine (core@ shell) nanoparticles via physical-chemical stimuli of polydopamine\/gold composites","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1185","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/10929080802551274","article-title":"A computer-assisted protocol for endovascular target interventions using a clinical MRI system for controlling untethered microdevices and future nanorobots","volume":"13","author":"Martel","year":"2008","journal-title":"Comput Aided Surg"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1190","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1002\/anie.201100115","article-title":"Micromachine-enabled capture and isolation of cancer cells in complex media","volume":"50","author":"Balasubramanian","year":"2011","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1195","first-page":"15","article-title":"Nanorobotics ideas in nanomedicine","volume":"3","author":"Patel","year":"2013","journal-title":"Asian J Pharm Sci Res"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1200","first-page":"2497","article-title":"Interventional procedure based on nanorobots propelled and steered by flagellated magnetotactic bacteria for direct targeting of tumors in the human body","volume":"2008","author":"Martel","year":"2008","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1205","first-page":"276","article-title":"Nanobots: The future of medical treatments","volume":"4","author":"Somanna","year":"2015","journal-title":"Int J Sci Tech Res"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1210","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1002\/smll.201400245","article-title":"A DNA origami nanorobot controlled by nucleic acid hybridization","volume":"10","author":"Torelli","year":"2014","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1215","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1126\/science.1214081","article-title":"A logic-gated nanorobot for targeted transport of molecular payloads","volume":"335","author":"Douglas","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1063\/1.2431454","article-title":"Bacterial flagella-based propulsion and on\/off motion control of microscale objects","volume":"90","author":"Behkam","year":"2007","journal-title":"Appl Phys Lett"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1166\/jctn.2003.003","article-title":"Computational studies of viral protein nano-actuators","volume":"1","author":"Dubey","year":"2004","journal-title":"J Comp Theor Nanosci"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1230","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.060_bb1235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11227-006-3845-z","article-title":"A survey on wireless grid computing","volume":"37","author":"Ahuja","year":"2006","journal-title":"J. Supercomput."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1240","first-page":"199","article-title":"Investigation into the future of RFID in biomedical applications","volume":"5119","author":"Ricciardi","year":"2003","journal-title":"Proc. SPIE - Int. Soc. Opt. Eng."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41565-020-0687-4","article-title":"Nanoscale nights of COVID-19","volume":"15","author":"Kostarelos","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1250","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jconrel.2020.08.060_bb1255","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cca.2020.07.016","article-title":"COVID-19: Review and hematologic impact","volume":"510","author":"de Oliveira Toledo","year":"2020","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1260","first-page":"277e281","article-title":"COVID-19: From bench to bed side","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metabolic Syndrome"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1265","first-page":"597e603","article-title":"Troponin elevation in conditions other than acute coronary syndromes","volume":"7","author":"Tanindi","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1270","first-page":"1","article-title":"Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside","volume":"1","author":"Sahu","year":"2020","journal-title":"Lab Med"},{"key":"10.1016\/j.jconrel.2020.08.060_bb1275","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01697-15","article-title":"Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials","volume":"6","author":"Warnes","year":"2015","journal-title":"mBio"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920305010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920305010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:17:56Z","timestamp":1718421476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920305010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":255,"alternative-id":["S0168365920305010"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.060","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotheranostics against COVID-19: From multivalent to immune-targeted materials","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}